0001104659-23-059148.txt : 20230511 0001104659-23-059148.hdr.sgml : 20230511 20230511161547 ACCESSION NUMBER: 0001104659-23-059148 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230511 DATE AS OF CHANGE: 20230511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rickard Kathleen A. CENTRAL INDEX KEY: 0001836883 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 23911241 MAIL ADDRESS: STREET 1: C/O VERONA PHARMA PLC STREET 2: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4/A 1 tm2315205-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4/A 2023-05-01 2023-05-03 0 0001657312 Verona Pharma plc VRNA 0001836883 Rickard Kathleen A. 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 0 1 0 0 Chief Medical Officer 1 Ordinary Shares 2023-05-01 4 M 0 15000 A 2986136 D Restricted Share Units 2023-05-01 4 M 0 15000 0.00 D 2029-03-29 Ordinary Shares 15000 0 D Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer. Each Restricted Share Unit represented a contingent right to receive one (1) Ordinary Share of the Issuer (which may be represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer) subject to certain time- and performance-based vesting criteria. Consists of (i) 1,743,488 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which are represented by 217,936 ADSs); and (ii) 1,242,648 Ordinary Shares underlying 155,331 ADSs. This Form 4/A is being filed to report the vesting of certainly previously reported Restricted Share Units which was inadvertently omitted in the Form 4 filed on May 3, 2023. The aggregate total in column 5 of Table I hereof reflects the total aggregate holdings after accounting for the sales reported in the Form 4 filed on May 3, 2023. /s/ Claire Poll, Attorney-in-fact for Kathleen A. Rickard 2023-05-11